Jun Shimizu

Active 1982–2024

74
Papers
18,695
Citations
45
h-index
65
i10-index

Citations

Citations per year for Jun Shimizu1967: 1 citations1985: 2 citations1986: 2 citations1988: 1 citations1989: 2 citations1991: 1 citations1992: 6 citations1993: 7 citations1994: 6 citations1995: 10 citations1996: 14 citations1997: 13 citations1998: 16 citations1999: 28 citations2000: 65 citations2001: 147 citations2002: 197 citations2003: 316 citations2004: 416 citations2005: 404 citations2006: 411 citations2007: 370 citations2008: 316 citations2009: 268 citations2010: 238 citations2011: 192 citations2012: 202 citations2013: 135 citations2014: 114 citations2015: 106 citations2016: 114 citations2017: 101 citations2018: 120 citations2019: 425 citations2020: 410 citations2021: 436 citations2022: 304 citations2023: 234 citations2024: 312 citations2025: 140 citations2026: 6 citations1968–1984: no citations, so these years are not shown1987: no citations, so this year is not shown1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,140 citing papers, 31.1% of this breakdownChina: 676 citing papers, 9.8% of this breakdownJapan: 570 citing papers, 8.3% of this breakdownUnited Kingdom: 500 citing papers, 7.3% of this breakdownGermany: 406 citing papers, 5.9% of this breakdownFrance: 276 citing papers, 4% of this breakdownItaly: 235 citing papers, 3.4% of this breakdownAustralia: 197 citing papers, 2.9% of this breakdownCanada: 196 citing papers, 2.8% of this breakdownNetherlands: 169 citing papers, 2.4% of this breakdownSpain: 98 citing papers, 1.4% of this breakdownSweden: 94 citing papers, 1.4% of this breakdown
0%31.1%Other 19.3%

Fields

  • Immunology and Microbiology44.8%
  • Medicine33.5%
  • Biochemistry, Genetics and Molecular Biology12.7%
  • Neuroscience6.4%
  • Engineering1%
  • Agricultural and Biological Sciences0.4%
  • Other1.2%

Topics

  • Immune Cell Function and Interaction14.3%
  • T-cell and B-cell Immunology13.9%
  • Immunotherapy and Immune Responses9.6%
  • Cancer Immunotherapy and Biomarkers4.6%
  • CAR-T cell therapy research2.5%
  • Diabetes and associated disorders1.5%
  • Other53.6%

Coauthors

All papers

Open in search
  1. Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4

    Authors: , , , , , , , - The Journal of Experimental Medicine 2000 cited by 2,213

  2. Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takuya Sasaki, Yusuke Sugiyama, Masashi Hamada, Gaku Ohtomo, Yasuo Terao, Yoshihiko Nakazato, Akitoshi Takeda, Yoshio Sakiyama, Yumi Umeda‐Kameyama, Jun Shinmi, Katsuhisa Ogata, Yutaka Kohno, Shen‐Yang Lim, Ai Huey Tan, Jun Shimizu, Jun Goto, Ichizo Nishino, Tatsushi Toda, Shinichi Morishita, Shoji Tsuji - Nature Genetics 2019 cited by 447

  3. Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity

    Authors: , , - The Journal of Immunology 1999 cited by 1,479

  4. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance

    Authors: , , , , - Nature Immunology 2002 cited by 1,723

  5. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.

    Authors: , , , , , , , - International Immunology 1998 cited by 1,548

  6. Chemokines and chemokine receptors as promising targets in rheumatoid arthritis

    Authors: , , , , - Frontiers in Immunology 2023 cited by 84

  7. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

    Authors: , , , , , - 1999 cited by 1,061

  8. Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease

    Authors: , , , , , , , , - Immunological Reviews 2006 cited by 1,532

  9. Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Norio Kanesawa, Takayuki Kondo, Takefumi Hitomi, Masayoshi Tada, Hiroki Takano, Yutaka Saitō, Kazuhiro Sanpei, Osamu Onodera, Masatoyo Nishizawa, Masayuki Nakamura, Takeshi Yasuda, Yoshio Sakiyama, Mieko Otsuka, Akira Ueki, K. Kaida, Jun Shimizu, Ritsuko Hanajima, Toshihiro Hayashi, Yasuo Terao, Satomi Inomata‐Terada, Masashi Hamada, Yuichiro Shirota, Akatsuki Kubota, Yoshikazu Ugawa, Kishin Koh, Yoshihisa Takiyama, Natsumi Ohsawa-Yoshida, Shoichi Ishiura, Ryo Yamasaki, Akira Tamaoka, Hiroshi Akiyama, Taisuke Otsuki, Akira Sano, Akio Ikeda, Jun Goto, Shinichi Morishita, Shoji Tsuji - Nature Genetics 2018 cited by 335

  10. Relative abundance of Megamonas hypermegale and Butyrivibrio species decreased in the intestine and its possible association with the T cell aberration by metabolite alteration in patients with Behcet’s disease (210 characters)

    Authors: , , , , , , , , , - Clinical Rheumatology 2019 cited by 76

  11. Bifidobacteria Abundance-Featured Gut Microbiota Compositional Change in Patients with Behcet’s Disease

    Authors: , , , , , , , , , - PLoS ONE 2016 cited by 125

  12. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

    Authors: , , , , , , , , , - Immunological Reviews 2001 cited by 1,513

  13. Thymus and Autoimmunity: Production of CD25+CD4+ Naturally Anergic and Suppressive T Cells as a Key Function of the Thymus in Maintaining Immunologic Self-Tolerance

    Authors: , , , , , , - The Journal of Immunology 1999 cited by 1,198

  14. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3 + CD25 + CD4 + regulatory T cells

    Authors: , , , , , , , , , - The Journal of Experimental Medicine 2005 cited by 463

  15. Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy

    Authors: , , , , , , , , , , , , , , , , , , , , - Neurology Neuroimmunology & Neuroinflammation 2016 cited by 102

  16. Propionate-producing bacteria in the intestine may associate with skewed responses of IL10-producing regulatory T cells in patients with relapsing polychondritis

    Authors: , , , , , , , , , , - PLoS ONE 2018 cited by 94

  17. Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells

    Authors: , , , , , , , , , , , - Scientific Reports 2022 cited by 48

  18. Restoration of spatial memory dysfunction of human APP transgenic mice by transplantation of neuronal precursors derived from human iPS cells

    Authors: , , , , , , , , , , - Neuroscience Letters 2013 cited by 83

  19. Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Shimizu, Keishi Fujio, Hirofumi Amano, Akio Mimori, Atsushi Kawakami, Hisanori Umehara, Tsutomu Takeuchi, Hajime Sano, Yoshinao Muro, Tatsuya Atsumi, Toshihide Mimura, Yasushi Kawaguchi, Tsuneyo Mimori, Atsushi Takahashi, Michiaki Kubo, Hitoshi Kohsaka, Takayuki Sumida, Kazuhiko Yamamoto - Annals of the Rheumatic Diseases 2018 cited by 75

  20. IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay

    Authors: , , , , , , , , , , , , , - Journal of Neuroimmunology 2016 cited by 91

  21. Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists

    Authors: , , , , , , , , , , , , - Modern Rheumatology 2018 cited by 85

  22. HMGB1 facilitates repair of mitochondrial DNA damage and extends the lifespan of mutant ataxin‐1 knock‐in mice

    Authors: , , , , , , , , , , - EMBO Molecular Medicine 2014 cited by 85

  23. Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein

    Authors: , , , , , , , , , , , , , , , - Scientific Reports 2022 cited by 25

  24. Control of Autoimmune Myocarditis and Multiorgan Inflammation by Glucocorticoid-Induced TNF Receptor Family-Related Proteinhigh, Foxp3-Expressing CD25+ and CD25− Regulatory T Cells

    Authors: , , , - The Journal of Immunology 2006 cited by 161